Wound Infiltration as Part of an Opioid Free Pain Management Pathway Following Cesarean Delivery
Status unconfirmed · Phase 2 · Has a placebo group
Conditions studied: Pain, Postoperative, Anesthesia, Local, Opioid Use
In brief
This study will investigate the effect of three types of wound infiltration on post Cesarean opioid analgesia consumption when used in conjunction with an opioid free postoperative analgesia pathway.
Key facts
- Study ID
- NCT03545516
- Run by
- Richmond University Medical Center
- People needed
- 540
- Starts
- 2018-09-17
- Expected to finish
- 2018-11-01
- Last updated by the study team
- 2018-08-29
Who can join
Age: 18 and older, up to 55. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- All scheduled Cesarean deliveries with intrathecal or epidural anesthesia
You may not qualify if…
- Emergency Cesarean deliveries
- Multifetal gestation
- Subjects <18 years old
- Subjects belonging to a vulnerable population (including subjects with a known opioid addiction, subjects with a history of mental illness and prisoners)
- Cesarean delivery with general anesthesia
- Known allergy or hypersensitivity to any of the study medications
- Subjects that can't comprehend the visual analog scale for quantitative pain assessment
Where it is running
- Richmond University Medical Center — Staten Island, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.